|
Pierre Talbot
Dr. Pierre Talbot obtained his B.Sc. in Biochemistry (1977) from the Faculty of Sciences and Engineering of Laval University and his Ph.D. in Biochemistry (1981) from the Department of Biochemistry, Faculty of Medicine, University of British Columbia in Vancouver.
After post-doctoral training in immunovirology with Drs. Michael Buchmeier and Michael Oldstone at the Scripps Research Institute in La Jolla (California), he joined (in 1984) the Armand-Frappier Institute as an NSERC University Research Fellow and then FRSQ Senior Scholar of Exceptional Merit until 1997.
Between 1998 and 2002, he was Director of the Human Health Research Centre of INRS-Institut Armand-Frappier, and was Director of INRS-Institut Armand-Frappier between 2002 and 2007.
The research efforts
of his team, funded by
Canadian Institutes of Health Research (CIHR) and
the National
Sciences and Engineering Research Council of Canada (NSERC), are aimed at an understanding of the interactions between a neurotropic virus and the immune and nervous systems that leads to the triggering of some neurologic diseases. The immediate target is the coronavirus as a possible etiological agent of multiple sclerosis.
Since 2003, Dr. Talbot holds a Tier I (senior) Canada Research Chair in NeuroImmunoVirology, and participates in the CIHR NeuroinflammationTraining Program
General information
INRS-Institut Armand-Frappier
531 boulevard des Prairies
Laval, Québec, H7V 1B7
Phone: (450) 687-5010
Fax : (450) 686-5501
Email address
|